Geode Capital Management, LLC Tempest Therapeutics, Inc. Call Options Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TPST
# of Institutions
34Shares Held
1.43MCall Options Held
161KPut Options Held
78K-
Black Rock Inc. New York, NY508KShares$1.07 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$371,7670.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$273,4110.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX106KShares$222,8160.05% of portfolio
-
Bank Of America Corp Charlotte, NC43KShares$90,7910.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $22M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...